title: Monodisperse Micro-Oil Droplets Stabilized by Polymerizable Phospholipid Coatings as Potential Drug Carriers.
abstract: There is a critical need to formulate stable micron-sized oil droplets as hydrophobic drug carriers for efficient drug encapsulation, long-term storage, and sustained drug release. Microfluidic methods were developed to maximize the stability of micron-sized, oil-in-water (o/w) emulsions for potential use in drug delivery, using doxorubicin-loaded triacetin oil as a model hydrophobic drug formulation. Initial experiments examined multiple flow conditions for the dispersed (oil) and continuous (liposome aqueous) phases in a microfluidic device to establish the parameters that influenced droplet size. These data were fit to a mathematical model from the literature and indicate that the droplet sizes formed are controlled by the ratio of flow rates and the height of the device channel, rather than the orifice size. Next, we investigated effects of o/w emulsion production methods on the stability of the droplets. The stability of o/w emulsion produced by microfluidic flow-focusing techniques was found to be much greater (5 h vs 1 h) than for emulsions produced by mechanical agitation (vortexing). The increased droplet stability was attributed to the uniform size and lipid distribution of droplets generated by flow-focusing. In contrast, vortexed populations consisted of a wide size distribution that resulted in a higher prevalence of Ostwald ripening. Finally, the effects of shell polymerization on stability were investigated by comparing oil droplets encapsulated by a photopolymerizable diacetylene lipid shell to those with a nonpolymerizable lipid shell. Shell polymerization was found to significantly enhance stability against dissolution for flow-focused oil droplets but did not significantly affect the stability of vortexed droplets. Overall, results of these experiments show that flow-focusing is a promising technique for generating tunable, stable, monodisperse oil droplet emulsions, with potential applications for controlled delivery of hydrophobic drug formulations.
authors: Yoonjee
authors: Y
authors: Park
authors: Tuan A
authors: TA
authors: Pham
authors: Carl
authors: C
authors: Beigie
authors: Mario
authors: M
authors: Cabodi
authors: Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford , Old Road Campus Research Building, Oxford, OX3 7DQ, United Kingdom.
authors: Robin O
authors: RO
authors: Cleveland
authors: NanoValent Pharmaceuticals, Inc. , 910 Technology Boulevard STE G, Bozeman, Montana 59718, United States.
authors: Jon O
authors: JO
authors: Nagy
authors: Joyce Y
authors: JY
authors: Wong
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D020099:Coated Materials, Biocompatible; D004317:Doxorubicin / Q000008:administration & dosage; D004337:Drug Carriers; D009821:Oils; D010743:Phospholipids / Q000737:chemistry*; D058105:Polymerization
chemical_list: D000903:Antibiotics, Antineoplastic; D020099:Coated Materials, Biocompatible; D004337:Drug Carriers; D009821:Oils; D010743:Phospholipids; D004317:Doxorubicin